Topical anti-infectives with corticosteroids

Day 30: Zydus receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole Capsules
Day 29: Zydus receives EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad
Day 24: Zydus receives final approval from the USFDA for Candesartan Cilexetil Tablets
Day 23: Zydus receives final approval from the USFDA for Ziprasidone Hydrochloride Capsules
Day 22: Zydus receives final approval from the USFDA for Pindolol Tablets USP
Day 17: Zydus receives final approval from the USFDA for Telmisartan and Hydrochlorothiazide Tablets
Day 16: Zydus receives final approval from the USFDA for Tiadylt ER Capsules and Azelastine Hydrochloride Nasal Spray
Day 14: Zydus announces settlement with Aptalis on CANASA® (mesalamine suppository, 1 g)
Day 11: Zydus receives tentative approval from the USFDA for Mesalamine Suppositories for rectal use
Day 10: Zydus Wellness’ Consolidated Net Profit up by % in Q1
Day 9: Zydus receives final approval from the USFDA for Diltiazem Hydrochloride Extended-Release Capsules USP
Day 8: Zydus receives tentative approval from the USFDA for Abacavir and Lamivudine Tablets USP
Day 5: Press Release USFDA approval Memantine Hydrochloride ER Capsules
Day 1: Zydus receives final approval from the USFDA for Temozolomide Capsules and Nadolol Tablets USP

Topical anti-infectives with corticosteroids

topical anti-infectives with corticosteroids

Media:

topical anti-infectives with corticosteroidstopical anti-infectives with corticosteroidstopical anti-infectives with corticosteroidstopical anti-infectives with corticosteroidstopical anti-infectives with corticosteroids